Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report

RATIONALE: Anti-thrombosis therapy for atrial fibrillation (AF) management and stroke prevention is an important aspect of disease management. Novel oral anticoagulants (NOACs) are recommended by guidelines for AF management. However, if one can switch one NOAC to another when the former showed a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Huan, Zhao, Qini, Wang, Yanjing, Lakin, Robert, Liu, Xueyan, Yu, Ming, Yang, Hongliang, Gao, Dongmei, Chen, Weiwei, Gao, Guangyuan, Yan, Mengjie, He, Yuquan, Yang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319865/
https://www.ncbi.nlm.nih.gov/pubmed/30572474
http://dx.doi.org/10.1097/MD.0000000000013623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319865/
https://www.ncbi.nlm.nih.gov/pubmed/30572474
http://dx.doi.org/10.1097/MD.0000000000013623

Ejemplares similares